Vaccine trials during a pandemic: potential approaches to ethical dilemmas
Abstract Ever since the emergence of the coronavirus disease 2019 (COVID-19), global public health infrastructures and systems, along with community-wide collaboration and service, have risen to an unprecedented challenge. Vaccine development was immediately propelled to the centre of all our scient...
Main Authors: | Manaf Alqahtani, Saad I. Mallah, Nigel Stevenson, Sally Doherty |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-021-05597-8 |
Similar Items
-
Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants
by: Jenna Rose Stoehr, et al.
Published: (2021-06-01) -
Clinical trials during the COVID-19 pandemic: Challenges of putting scientific and ethical principles into practice
by: Arun Bhatt
Published: (2020-01-01) -
Medical ethics in theses and clinical trials in Babol University of Medical Sciences, 2001
by: Y ZahedPasha, et al.
Published: (2003-07-01) -
Utilization of Viral Vector Vaccines in Preparing for Future Pandemics
by: Kimberly A. Hofmeyer, et al.
Published: (2022-03-01) -
Ethical allocation of scarce vaccine doses: The Priority-Equality protocol
by: Carlos Alós-Ferrer, et al.
Published: (2022-12-01)